Cargando…

Pharmacology and physiology of gastrointestinal enteroendocrine cells

Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mace, O J, Tehan, B, Marshall, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/
https://www.ncbi.nlm.nih.gov/pubmed/26213627
http://dx.doi.org/10.1002/prp2.155
_version_ 1782381726383734784
author Mace, O J
Tehan, B
Marshall, F
author_facet Mace, O J
Tehan, B
Marshall, F
author_sort Mace, O J
collection PubMed
description Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein-coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux-en-Y gastric surgery. Typically obese patients exhibit ∼30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self-limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system.
format Online
Article
Text
id pubmed-4506687
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45066872015-07-24 Pharmacology and physiology of gastrointestinal enteroendocrine cells Mace, O J Tehan, B Marshall, F Pharmacol Res Perspect Invited Reviews Gastrointestinal (GI) polypeptides are secreted from enteroendocrine cells (EECs). Recent technical advances and the identification of endogenous and synthetic ligands have enabled exploration of the pharmacology and physiology of EECs. Enteroendocrine signaling pathways stimulating hormone secretion involve multiple nutrient transporters and G protein-coupled receptors (GPCRs), which are activated simultaneously under prevailing nutrient conditions in the intestine following a meal. The majority of studies investigate hormone secretion from EECs in response to single ligands and although the mechanisms behind how individual signaling pathways generate a hormonal output have been well characterized, our understanding of how these signaling pathways converge to generate a single hormone secretory response is still in its infancy. However, a picture is beginning to emerge of how nutrients and full, partial, or allosteric GPCR ligands differentially regulate the enteroendocrine system and its interaction with the enteric and central nervous system. So far, activation of multiple pathways underlies drug discovery efforts to harness the therapeutic potential of the enteroendocrine system to mimic the phenotypic changes observed in patients who have undergone Roux-en-Y gastric surgery. Typically obese patients exhibit ∼30% weight loss and greater than 80% of obese diabetics show remission of diabetes. Targeting combinations of enteroendocrine signaling pathways that work synergistically may manifest with significant, differentiated EEC secretory efficacy. Furthermore, allosteric modulators with their increased selectivity, self-limiting activity, and structural novelty may translate into more promising enteroendocrine drugs. Together with the potential to bias enteroendocrine GPCR signaling and/or to activate multiple divergent signaling pathways highlights the considerable range of therapeutic possibilities available. Here, we review the pharmacology and physiology of the EEC system. John Wiley & Sons, Ltd 2015-08 2015-07-07 /pmc/articles/PMC4506687/ /pubmed/26213627 http://dx.doi.org/10.1002/prp2.155 Text en © 2015 The Heptares Therapeutics. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Invited Reviews
Mace, O J
Tehan, B
Marshall, F
Pharmacology and physiology of gastrointestinal enteroendocrine cells
title Pharmacology and physiology of gastrointestinal enteroendocrine cells
title_full Pharmacology and physiology of gastrointestinal enteroendocrine cells
title_fullStr Pharmacology and physiology of gastrointestinal enteroendocrine cells
title_full_unstemmed Pharmacology and physiology of gastrointestinal enteroendocrine cells
title_short Pharmacology and physiology of gastrointestinal enteroendocrine cells
title_sort pharmacology and physiology of gastrointestinal enteroendocrine cells
topic Invited Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506687/
https://www.ncbi.nlm.nih.gov/pubmed/26213627
http://dx.doi.org/10.1002/prp2.155
work_keys_str_mv AT maceoj pharmacologyandphysiologyofgastrointestinalenteroendocrinecells
AT tehanb pharmacologyandphysiologyofgastrointestinalenteroendocrinecells
AT marshallf pharmacologyandphysiologyofgastrointestinalenteroendocrinecells